These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 28575767)
21. Antiepileptic drug prescribing patterns in Iraq and Afghanistan war veterans with epilepsy. Rohde NN; Baca CB; Van Cott AC; Parko KL; Amuan ME; Pugh MJ Epilepsy Behav; 2015 May; 46():133-9. PubMed ID: 25911209 [TBL] [Abstract][Full Text] [Related]
22. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252 [TBL] [Abstract][Full Text] [Related]
23. Use of antiepileptic drugs and lipid-lowering agents in the United States. Mintzer S; Maio V; Foley K Epilepsy Behav; 2014 May; 34():105-8. PubMed ID: 24735835 [TBL] [Abstract][Full Text] [Related]
24. Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy. Meador KJ; Pennell PB; May RC; Gerard E; Kalayjian L; Velez-Ruiz N; Penovich P; Cavitt J; French J; Hwang S; Pack AM; Sam M; Moore E; Ippolito DM; Epilepsy Behav; 2018 Jul; 84():10-14. PubMed ID: 29730500 [TBL] [Abstract][Full Text] [Related]
25. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629 [TBL] [Abstract][Full Text] [Related]
26. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits. Stephen LJ; Wishart A; Brodie MJ Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500 [TBL] [Abstract][Full Text] [Related]
27. Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice. Josephson CB; Engbers JDT; Jette N; Patten SB; Sajobi TT; Marshall D; Lowerison M; Wiebe S Epilepsy Behav; 2018 Jul; 84():49-55. PubMed ID: 29753294 [TBL] [Abstract][Full Text] [Related]
28. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
29. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients. Böttcher S; Lutz MT; Mayer T Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872 [TBL] [Abstract][Full Text] [Related]
30. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations. Mercadé Cerdá JM; López Gonzalez FJ; Serrano Castro P; Castro Vilanova MD; Campos Blanco DM; Querol Pascual MR; Neurologia (Engl Ed); 2020 Mar; 35(2):115-125. PubMed ID: 29530436 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities. O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463 [TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341 [TBL] [Abstract][Full Text] [Related]
33. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database. Nicholas JM; Ridsdale L; Richardson MP; Ashworth M; Gulliford MC Seizure; 2012 Jul; 21(6):466-70. PubMed ID: 22608976 [TBL] [Abstract][Full Text] [Related]
34. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort. McGinnis E; Kessler SK Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability. Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359 [TBL] [Abstract][Full Text] [Related]
36. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction? Novy J; Patsalos PN; Sander JW; Sisodiya SM Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937 [TBL] [Abstract][Full Text] [Related]
37. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States. Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339 [TBL] [Abstract][Full Text] [Related]
38. Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. Alacqua M; Trifirò G; Spina E; Moretti S; Tari DU; Bramanti P; Caputi AP; Arcoraci V Epilepsy Res; 2009 Jul; 85(1):107-13. PubMed ID: 19345564 [TBL] [Abstract][Full Text] [Related]
39. The effects of lacosamide on depression and anxiety in patients with epilepsy. Moseley BD; Cole D; Iwuora O; Strawn JR; Privitera M Epilepsy Res; 2015 Feb; 110():115-8. PubMed ID: 25616463 [TBL] [Abstract][Full Text] [Related]
40. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Hsieh LP; Huang CY Epilepsy Res; 2011 Sep; 96(1-2):81-8. PubMed ID: 21632214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]